In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Lombard Medical Technologies hopes to raise up to £25.3mm privately

Executive Summary

Lombard Medical Technologies PLC (cardiovascular devices) is hoping to raise up to £25.3mm ($41.8mm) through a two-tranche financing. Abingworth and MVM Life Science Partners have agreed to invest £13mm (combined), which will give the backers an 8.3% and 13.45% stake in the company, respectively. (The company’s largest shareholder, IAML, will hold a 42.1% share unless it chooses to participate.)
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Site Specific
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies